Compounds > furegrelate

furegrelate and 6-ketoprostaglandin f1 alpha

furegrelate has been researched along with 6-ketoprostaglandin f1 alpha in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (70.00)	18.7374
1990's	3 (30.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bolling, SF; Deeb, GM; Grum, CM; Ljungman, AG; Morganroth, ML	1
Glovsky, MM; Horvath, SJ; Morganroth, ML; Schoeneich, SO; Till, GO; Ward, PA	1
Clark, WF; Kreeft, J; McDonald, JW; Parbtani, A; Reid, BD; Taylor, N	1
Lawson, DL; Mehta, JL; Nichols, WW	1
Gréen, K; Vesterqvist, O	1
Cronenwett, JL; Huntsman, WT; McDaniel, MD; Miett, TO	1
Datar, S; McCauley, FA; Wilson, TW	1
Keith, JC; Schaub, RG; Thatcher, CD	1
Anner, H; Hechtman, HB; Kaufman, RP; Kobzik, L; Shepro, D; Valeri, CR	1
Badahman, AH; Kaushal, RD; Wilson, TW	1

Other Studies

10 other study(ies) available for furegrelate and 6-ketoprostaglandin f1 alpha

Article	Year
Inhibition of cyclooxygenase metabolite production attenuates ischemia-reperfusion lung injury. The American review of respiratory disease, 1991, Volume: 143, Issue:3 Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzofurans; Blood Pressure; Cyclooxygenase Inhibitors; Dinoprost; Flurbiprofen; Hydrogen Peroxide; Indomethacin; Lung; Male; Prostaglandin-Endoperoxide Synthases; Pulmonary Artery; Rats; Rats, Inbred Strains; Reperfusion Injury; Thromboxane B2; Thromboxane-A Synthase	1991
C3a57-77, a C-terminal peptide, causes thromboxane-dependent pulmonary vascular constriction in isolated perfused rat lungs. The American review of respiratory disease, 1990, Volume: 141, Issue:2 Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzofurans; Blood Pressure; Complement C3a; Cyclooxygenase Inhibitors; Imidazoles; In Vitro Techniques; Indomethacin; Lung; Male; Peptide Fragments; Perfusion; Pyridines; Rats; Thromboxane B2; Thromboxane-A Synthase; Vasoconstriction	1990
The effects of a thromboxane synthase inhibitor, a prostacyclin analog and PGE1 on the nephritis of the NZB/W F1 mouse. Clinical nephrology, 1987, Volume: 28, Issue:6 Topics: 6-Ketoprostaglandin F1 alpha; Age Factors; Alprostadil; Animals; Benzofurans; Blood Pressure; Disease Models, Animal; Epoprostenol; Female; Iloprost; Lupus Nephritis; Mice; Mice, Inbred NZB; Mice, Inbred Strains; Nephritis; Proteinuria; Thromboxane B2; Vasodilator Agents	1987
Attenuated coronary relaxation after reperfusion: effects of superoxide dismutase and TxA2 inhibitor U 63557A. The American journal of physiology, 1989, Volume: 257, Issue:4 Pt 2 Topics: 6-Ketoprostaglandin F1 alpha; Acetylcholine; Animals; Benzofurans; Blood Platelets; Coronary Vessels; Dogs; Female; Male; Muscle, Smooth, Vascular; Myocardial Reperfusion; Neutrophils; Recombinant Proteins; Reference Values; SRS-A; Superoxide Dismutase; Superoxides; Thromboxane A2; Thromboxane-A Synthase; Vasodilation	1989
In vivo synthesis of thromboxane and prostacyclin in man in health and disease. Data from GC-MS measurements of major urinary metabolites. Advances in prostaglandin, thromboxane, and leukotriene research, 1986, Volume: 16 Topics: 6-Ketoprostaglandin F1 alpha; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Blood Vessel Prosthesis; Epoprostenol; Gas Chromatography-Mass Spectrometry; Humans; Myocardial Infarction; Thromboxane A2; Thromboxane B2	1986
Effect of a selective thromboxane synthase inhibitor on arterial graft patency and platelet deposition in dogs. Archives of surgery (Chicago, Ill. : 1960), 1987, Volume: 122, Issue:8 Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Animals; Arteries; Aspirin; Benzofurans; Blood Platelets; Blood Vessel Prosthesis; Carotid Arteries; Dipyridamole; Dogs; Female; Indium; Polyethylene Terephthalates; Polytetrafluoroethylene; Radioisotopes; Random Allocation; Thromboxane B2; Thromboxane-A Synthase	1987
Testing the "redirection hypothesis" of prostaglandin metabolism in the kidney. Prostaglandins, 1987, Volume: 33, Issue:2 Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzofurans; Drug Interactions; Furosemide; Kidney; Male; Prostaglandins; Rats; Rats, Inbred Strains; Renin; Thromboxane B2; Thromboxane-A Synthase	1987
Beneficial effects of U-63,557A, a thromboxane synthetase inhibitor, in an ovine model of pregnancy-induced hypertension. American journal of obstetrics and gynecology, 1987, Volume: 157, Issue:1 Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzofurans; Blood Pressure; Female; Hypertension; Kidney Function Tests; Platelet Count; Pregnancy; Pregnancy Complications, Cardiovascular; Sheep; Thromboxane B2; Thromboxane-A Synthase; Uterus	1987
A high plasma prostaglandin to thromboxane ratio protects against renal ischemia. Surgery, gynecology & obstetrics, 1987, Volume: 165, Issue:5 Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzofurans; Creatinine; Evaluation Studies as Topic; Ibuprofen; Imidazoles; Ischemia; Kidney; Kidney Tubular Necrosis, Acute; Male; Methacrylates; Pyridines; Rats; Thromboxane B2; Thromboxane-A Synthase	1987
Thromboxane synthase inhibition enhances furosemide-induced renal vasodilation. Clinical and investigative medicine. Medecine clinique et experimentale, 1993, Volume: 16, Issue:5 Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzofurans; Diuresis; Drug Interactions; Furosemide; Indomethacin; Kidney; Male; p-Aminohippuric Acid; Rats; Rats, Sprague-Dawley; Thromboxane-A Synthase; Vasodilation	1993